Molbio Diagnostics IPO allotment is expected on Thursday after the Rs 939.70-crore issue was subscribed 70.26 times. With a grey market premium of around 20%, investors await allotment results ahead of the August 17 listing. Proceeds will fund R&D infrastructure, manufacturing expansion and corporate purposes, while FY26 revenue grew 42% year-on-year.